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Tuinman and colleagues report the results of a single-
institution study in cardiac surgery patients (n = 45), 
docu  menting that bronchoalveolar lavage ﬂ  uid cytokine 
and coagulation markers were signiﬁ  cantly increased in a 
dose-dependent manner with transfusions [1]. Th  ey 
conclude that transfusion was associated with activation 
of pulmonary inﬂ   ammation/coagulation and systemic 
coagu lation  derangement.
Th   e data are interesting and provocative, and provide a 
biologic basis for observational studies that reported an 
association between red blood cell (RBC) transfusions 
and increased pulmonary complications, including acute 
lung injury and acute respiratory distress syndrome [2,3]. 
Translational research studies like this are needed to 
move this ﬁ  eld forward.
Although increased inﬂ  ammatory/coagulation markers 
were identiﬁ   ed in the multiple transfusion cohort, no 
clinically relevant diﬀ   erence in pulmonary function 
(includ  ing the PaO2/FiO2 ratio) was identiﬁ  ed [1]. Dura-
tion of mechanical ventilation was longer in the multiple 
transfusion cohort, but all were of less than 1 day duration.
A major study limitation is that the three cohorts were 
not deﬁ  ned on the basis of RBC transfusions alone, as the 
multiple transfusion cohort received plasma/platelets in 
addition to RBC transfusions. Th  is factor signiﬁ  cantly 
confounds the issue, as plasma administration is asso-
ciated with signiﬁ   cantly increased risk for pulmonary 
complications [4-7]. In a systematic review/meta-analysis 
of 37 studies, plasma transfusion was associated with 
signiﬁ  cantly increased acute lung injury risk (odds ratio, 
2.92; 95% conﬁ  dence interval, 1.99 to 4.29) [8].
Most importantly, the eﬀ  ects of anticoagulants, heparin 
antagonists (for example, protamine) or blood-saving 
strategies (for example, cell-saver technique) and the 
degree of intraoperative blood loss and hypoperfusion/
shock were not considered. Additional study limitations 
include the small sample size, and increased EuroSCORE 
in the multiple transfusion cohort, and an inability to 
assess age of blood as a variable.
Th   e fundamental question of whether RBC transfusion 
is safe/eﬀ  ective in cardiac surgery is important, and this 
current study highlights signiﬁ  cant concerns particularly 
with regard to pulmonary complications. Signiﬁ  cant 
variability in transfusion use in cardiac surgery persists, 
ranging from 7.8 to 92.8% for RBC transfusion [9]. Th  e 
Transfusion Requirements in Critical Care trial excluded 
cardiac surgical patients and patients who received trans-
fusions before admission to the ICU [10]. Th  e recent 
Transfusion Requirements After Cardiac Surgery trial – a 
single-center prospective, randomized clinical trial with 
patients (n = 502) randomized to a liberal strategy (main-
tain hematocrit ≥30%) or to a restrictive strategy (maintain 
hematocrit ≥24%) – reported that for each transfused 
RBC unit, the risk of respiratory complications increased 
(odds ratio, 1.27; 95% conﬁ  dence interval, 1.12 to 1.45; 
P <0.001) with no diﬀ  erence in 30-day all-cause mortality 
[11].
To resolve this issue regarding transfusion, a large 
multi  center, prospective, randomized clinical trial 
Abstract
Marked variability in transfusion practice exists 
in cardiac surgical patients, with consumption of 
approximately 20% of the worldwide allogeneic 
blood supply. Observational studies have reported an 
association between red blood cell transfusion and 
adverse outcome, including pulmonary complications, 
in cardiac surgery. Tuinman and colleagues report 
that transfusions were associated with activation 
of pulmonary infl  ammation and coagulation by 
measurement of biomarkers in bronchoalveolar 
lavage fl  uid, and suggest that transfusion may be a 
mediator of acute lung injury. This study provides 
interesting preliminary data, but is limited by multiple 
confounding variables (plasma transfusion, use of 
anticoagulants and heparin antagonists) and the 
small sample size. A large multicenter, prospective, 
randomized clinical trial regarding the safety (inclusive 
of pulmonary complications) and effi   cacy of red blood 
cell transfusion in cardiac surgery is needed.
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© 2011 BioMed Central Ltdregarding the safety (including pulmonary complications) 
and eﬃ     cacy of RBC transfusion in cardiac surgery is 
needed. Th  e National Heart, Lung, and Blood Institute 
established a State-of-the-Science Symposium on 
Transfusion Medi  cine to identify important clinical trial 
research issues in this ﬁ  eld, and a trial in cardiac surgery 
was strongly recommended [12].
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